Barclays PLC Buys New Stake in Protara Therapeutics, Inc. (NASDAQ:TARA)
Barclays PLC bought a new position in shares of Protara Therapeutics, Inc. (NASDAQ:TARA – Free Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor bought 93,239 shares of the company’s stock, valued at approximately $492,000. Several other hedge funds and other institutional investors also […]
More Stories
The Role of AI and IoT in Next-Gen Facility Management Solutions
What’s the sign of a well-run facility? For decades, this would have meant minimal downtime, and no service disruptions or...
Patricia Roche Net Worth, Career, and Her Role in The Beanie Bubble
Patricia Roche came into the limelight with her admirable role in Ty Warner’s Beanie Babies. Her contribution to Ty Inc.’s...
Cardinal Health, Inc. (NYSE:CAH) Shares Bought by Principal Financial Group Inc.
Principal Financial Group Inc. raised its position in Cardinal Health, Inc. (NYSE:CAH – Free Report) by 5.3% in the 1st...
Calamos Advisors LLC Sells 8,240 Shares of Piper Sandler Companies (NYSE:PIPR)
Calamos Advisors LLC lessened its position in Piper Sandler Companies (NYSE:PIPR – Free Report) by 77.1% during the first quarter,...
Mutual Advisors LLC Trims Stock Position in iShares U.S. Aerospace & Defense ETF (BATS:ITA)
Mutual Advisors LLC cut its stake in shares of iShares U.S. Aerospace & Defense ETF (BATS:ITA – Free Report) by...
Principal Financial Group Inc. Sells 5,395 Shares of EMCOR Group, Inc. (NYSE:EME)
Principal Financial Group Inc. reduced its position in shares of EMCOR Group, Inc. (NYSE:EME – Free Report) by 4.7% in...